These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25210839)

  • 21. The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding.
    Ghosh D; Sahay S; Ranjan P; Salot S; Mohite GM; Singh PK; Dwivedi S; Carvalho E; Banerjee R; Kumar A; Maji SK
    Biochemistry; 2014 Oct; 53(41):6419-21. PubMed ID: 25268550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
    Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
    J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tilted properties of the 67-78 fragment of alpha-synuclein are responsible for membrane destabilization and neurotoxicity.
    Crowet JM; Lins L; Dupiereux I; Elmoualija B; Lorin A; Charloteaux B; Stroobant V; Heinen E; Brasseur R
    Proteins; 2007 Sep; 68(4):936-47. PubMed ID: 17554782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway.
    Cappai R; Leck SL; Tew DJ; Williamson NA; Smith DP; Galatis D; Sharples RA; Curtain CC; Ali FE; Cherny RA; Culvenor JG; Bottomley SP; Masters CL; Barnham KJ; Hill AF
    FASEB J; 2005 Aug; 19(10):1377-9. PubMed ID: 15946991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane-induced initial structure of α-synuclein control its amyloidogenesis on model membranes.
    Terakawa MS; Lee YH; Kinoshita M; Lin Y; Sugiki T; Fukui N; Ikenoue T; Kawata Y; Goto Y
    Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):757-766. PubMed ID: 29273335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
    Rekas A; Ahn KJ; Kim J; Carver JA
    Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
    van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
    J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane lipid co-aggregation with α-synuclein fibrils.
    Hellstrand E; Nowacka A; Topgaard D; Linse S; Sparr E
    PLoS One; 2013; 8(10):e77235. PubMed ID: 24146972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High stability and cooperative unfolding of α-synuclein oligomers.
    Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE
    Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trifluoroethanol modulates α-synuclein amyloid-like aggregate formation, stability and dissolution.
    Di Carlo MG; Vetri V; Buscarino G; Leone M; Vestergaard B; Foderà V
    Biophys Chem; 2016 Sep; 216():23-30. PubMed ID: 27372900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.
    Jha S; Sellin D; Seidel R; Winter R
    J Mol Biol; 2009 Jun; 389(5):907-20. PubMed ID: 19427320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
    J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of different regions of alpha-synuclein in the assembly of fibrils.
    Qin Z; Hu D; Han S; Hong DP; Fink AL
    Biochemistry; 2007 Nov; 46(46):13322-30. PubMed ID: 17963364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ca(2+) modulating α-synuclein membrane transient interactions revealed by solution NMR spectroscopy.
    Zhang Z; Dai C; Bai J; Xu G; Liu M; Li C
    Biochim Biophys Acta; 2014 Mar; 1838(3):853-8. PubMed ID: 24316000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α-Synuclein oligomers: an amyloid pore? Insights into mechanisms of α-synuclein oligomer-lipid interactions.
    Stöckl MT; Zijlstra N; Subramaniam V
    Mol Neurobiol; 2013 Apr; 47(2):613-21. PubMed ID: 22956232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FRET studies of lipid-protein aggregates related to amyloid-like fibers.
    Coutinho A; Loura LM; Prieto M
    J Neurochem; 2011 Mar; 116(5):696-701. PubMed ID: 21214548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies.
    Nemes Z; Petrovski G; Aerts M; Sergeant K; Devreese B; Fésüs L
    J Biol Chem; 2009 Oct; 284(40):27252-64. PubMed ID: 19651786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Interaction of Alpha-synuclein with Membranes and its Implication in Parkinson's Disease: A Literature Review.
    Gonzalez-Horta A
    Nat Prod Commun; 2015 Oct; 10(10):1775-8. PubMed ID: 26669123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism.
    van Rooijen BD; Claessens MM; Subramaniam V
    PLoS One; 2010 Dec; 5(12):e14292. PubMed ID: 21179192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.